Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$165,000.00

Investigating invasive mechanical ventilation in patients with pneumonia and hypoxemic respiratory failure: which patients receive it, and which patients benefit?

EF 2020-21

Résumé
Pneumonia is a common, dangerous, and treatable cause of mortality and morbidity. More than 2 million people worldwide die from pneumonia each year, not including the accumulating mortality from the pandemic of Sars-Cov-2 infection. The burden of pneumonia falls disproportionately on people made vulnerable by age, frailty, poverty, insecure housing, or malnutrition. Treatments focus on antibiotics and supportive care, with severe cases frequently placed on invasive ventilatory life support via a process known as intubation. However, intubation and ventilation come with significant side effects including the danger of the intubation procedure and the risks of weakness, hospital-acquired infection, and delirium that are common after intubation. The decision to start invasive ventilation requires careful weighing of the risks and benefits, but there is almost no data available to assist physicians and patients in making this decision. Our project will investigate invasive ventilation for patients with pneumonia through careful observational analyses of large databases to determine (1) what clinical factors predict invasive ventilation and (2) which patients benefit from invasive ventilation. Our observational study will use a combination of cutting-edge techniques including the innovative "target trial" approach that reduces bias and the machine learning "causal forest" technique that helps identify which patients benefit the most from a therapy. This research will have immediate relevance by providing information on the benefit of invasive ventilation and longer-term relevance by helping to build the foundation for a definitive trial.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
441136
Name
Yarnell Christopher J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
Investigating invasive mechanical ventilation in patients with pneumonia and hypoxemic respiratory failure: which patients receive it, and which patients benefit?
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$165,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Artifical Respiration; Causal Inference; Covid-19; Critical Care Medicine; Critical Illness; Intubation; Machine Learning; Mechanical Ventilation; Pneumonia; Target Trial
Abstract
Pneumonia is a common, dangerous, and treatable cause of mortality and morbidity. More than 2 million people worldwide die from pneumonia each year, not including the accumulating mortality from the pandemic of Sars-Cov-2 infection. The burden of pneumonia falls disproportionately on people made vulnerable by age, frailty, poverty, insecure housing, or malnutrition. Treatments focus on antibiotics and supportive care, with severe cases frequently placed on invasive ventilatory life support via a process known as intubation. However, intubation and ventilation come with significant side effects including the danger of the intubation procedure and the risks of weakness, hospital-acquired infection, and delirium that are common after intubation. The decision to start invasive ventilation requires careful weighing of the risks and benefits, but there is almost no data available to assist physicians and patients in making this decision. Our project will investigate invasive ventilation for patients with pneumonia through careful observational analyses of large databases to determine (1) what clinical factors predict invasive ventilation and (2) which patients benefit from invasive ventilation. Our observational study will use a combination of cutting-edge techniques including the innovative "target trial" approach that reduces bias and the machine learning "causal forest" technique that helps identify which patients benefit the most from a therapy. This research will have immediate relevance by providing information on the benefit of invasive ventilation and longer-term relevance by helping to build the foundation for a definitive trial.
Competitiondate
202012
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yarnell, Christopher J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $165,000~ $0~